Labour attacks New Zealand's health reforms
This article was originally published in Clinica
New Zealand's healthcare system has become "a bureaucratic nightmare more concerned with financial risk management than giving people operations", claims Labour health spokesperson Lianne Dalziel. Ms Dalziel has seized on criticism of the health service by the former head of New Zealand's largest crown health enterprise (CHE), Auckland Healthcare, as proof that the country's health reforms are failing, reports GP Weekly.
You may also be interested in...
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.